
Molecule: PANITUMUMAB
ChEMBL ID: CHEMBL1201827
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2006

Molecule: CETUXIMAB
ChEMBL ID: CHEMBL1201577
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2004

Molecule: ERLOTINIB HYDROCHLORIDE
ChEMBL ID: CHEMBL1079742
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2004

Molecule: GEFITINIB
ChEMBL ID: CHEMBL939
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2003

Molecule: LAPATINIB DITOSYLATE
ChEMBL ID: CHEMBL1201179
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2007

Molecule: AFATINIB DIMALEATE
ChEMBL ID: CHEMBL2105712
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2013

Molecule: OSIMERTINIB MESYLATE
ChEMBL ID: CHEMBL3545063
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2015

Molecule: NECITUMUMAB
ChEMBL ID: CHEMBL1743047
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2015

Molecule: AC-480
ChEMBL ID: CHEMBL1645462
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: ALLITINIB
ChEMBL ID: CHEMBL1947204
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AZD-4769
ChEMBL ID: CHEMBL422872
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: FALNIDAMOL
ChEMBL ID: CHEMBL258940
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CEP-32496
ChEMBL ID: CHEMBL2029988
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CUDC-101
ChEMBL ID: CHEMBL598797
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: OLMUTINIB
ChEMBL ID: CHEMBL3786343
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2016

Molecule: THELIATINIB
ChEMBL ID: CHEMBL5314410
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: EPITINIB
ChEMBL ID: CHEMBL5314411
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: JNJ-26483327
ChEMBL ID: CHEMBL3109738
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: MP-412
ChEMBL ID: CHEMBL5095024
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PD-0166285
ChEMBL ID: CHEMBL3545196
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PKI-166
ChEMBL ID: CHEMBL1963502
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: S-222611
ChEMBL ID: CHEMBL3545200
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: TAK-285
ChEMBL ID: CHEMBL1614725
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PUQUITINIB MESYLATE DIHYDRATE
ChEMBL ID: CHEMBL4596972
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: PYROTINIB
ChEMBL ID: CHEMBL3647420
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: AEE-788
ChEMBL ID: CHEMBL587723
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BRIGATINIB
ChEMBL ID: CHEMBL3545311
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: VARLITINIB
ChEMBL ID: CHEMBL2103842
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SAPITINIB
ChEMBL ID: CHEMBL2408045
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BMS-690514
ChEMBL ID: CHEMBL3545396
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ROCILETINIB
ChEMBL ID: CHEMBL3545308
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: PELITINIB
ChEMBL ID: CHEMBL607707
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TESEVATINIB
ChEMBL ID: CHEMBL3544983
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: NAZARTINIB
ChEMBL ID: CHEMBL3787344
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: OSIMERTINIB
ChEMBL ID: CHEMBL3353410
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2015

Molecule: CANERTINIB DIHYDROCHLORIDE
ChEMBL ID: CHEMBL545315
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: NERATINIB
ChEMBL ID: CHEMBL180022
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: DACOMITINIB
ChEMBL ID: CHEMBL2105719
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: SIMOTINIB
ChEMBL ID: CHEMBL3545235
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ZALUTUMUMAB
ChEMBL ID: CHEMBL2107861
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Antibody

Molecule: MATUZUMAB
ChEMBL ID: CHEMBL2108038
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: MAB-425
ChEMBL ID: CHEMBL2109390
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: MDX-447
ChEMBL ID: CHEMBL2109391
Mechanism of Action: CROSS-LINKING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: RG-7160
ChEMBL ID: CHEMBL2109393
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: NIMOTUZUMAB
ChEMBL ID: CHEMBL2108359
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: FUTUXIMAB
ChEMBL ID: CHEMBL2109388
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Antibody

Molecule: DEPATUXIZUMAB MAFODOTIN
ChEMBL ID: CHEMBL3707277
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody drug conjugate

Molecule: DULIGOTUZUMAB
ChEMBL ID: CHEMBL3137345
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: IMGATUZUMAB
ChEMBL ID: CHEMBL2109389
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: DACOMITINIB ANHYDROUS
ChEMBL ID: CHEMBL2110732
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: NERATINIB MALEATE
ChEMBL ID: CHEMBL3989921
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: CETUXIMAB SAROTALOCAN
ChEMBL ID: CHEMBL4298088
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: FIRMONERTINIB
ChEMBL ID: CHEMBL4297258
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: PF-06459988
ChEMBL ID: CHEMBL3786098
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: DEPATUXIZUMAB
ChEMBL ID: CHEMBL3707294
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: MAVELERTINIB
ChEMBL ID: CHEMBL3989970
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: NAQUOTINIB
ChEMBL ID: CHEMBL3663929
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TOMUZOTUXIMAB
ChEMBL ID: CHEMBL4297842
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: FIRMONERTINIB
ChEMBL ID: CHEMBL4297258
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: AZD-3759
ChEMBL ID: CHEMBL3623290
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: AUMOLERTINIB
ChEMBL ID: CHEMBL4761468
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ICOTINIB
ChEMBL ID: CHEMBL2087361
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ABIVERTINIB MALEATE
ChEMBL ID: CHEMBL4297866
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ABIVERTINIB
ChEMBL ID: CHEMBL4297865
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: AUMOLERTINIB
ChEMBL ID: CHEMBL4761468
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ABIVERTINIB MALEATE
ChEMBL ID: CHEMBL4297866
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: ABIVERTINIB
ChEMBL ID: CHEMBL4297865
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MAVELERTINIB
ChEMBL ID: CHEMBL3989970
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MAVELERTINIB
ChEMBL ID: CHEMBL3989970
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MAVELERTINIB
ChEMBL ID: CHEMBL3989970
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: RUSERONTINIB
ChEMBL ID: CHEMBL3678958
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: TUXOBERTINIB
ChEMBL ID: CHEMBL4650279
Mechanism of Action: NEGATIVE ALLOSTERIC MODULATOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: CLN-081
ChEMBL ID: CHEMBL4650281
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: GC1118
ChEMBL ID: CHEMBL4650290
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: AMIVANTAMAB
ChEMBL ID: CHEMBL4297774
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2021

Molecule: RINDOPEPIMUT
ChEMBL ID: CHEMBL2107863
Mechanism of Action: VACCINE ANTIGEN
Max Phase: 3.0
Molecule Type: Unknown

Molecule: MOBOCERTINIB
ChEMBL ID: CHEMBL4650319
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2021

Molecule: MODOTUXIMAB
ChEMBL ID: CHEMBL3989988
Mechanism of Action: ANTAGONIST
Max Phase: 3.0
Molecule Type: Antibody

Molecule: LAZERTINIB
ChEMBL ID: CHEMBL4558324
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: LAZERTINIB
ChEMBL ID: CHEMBL4558324
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: PIMURUTAMAB
ChEMBL ID: CHEMBL4594549
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: EMB-01
ChEMBL ID: CHEMBL4594472
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Unknown

Molecule: MOBOCERTINIB SUCCINATE
ChEMBL ID: CHEMBL4802239
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2021

Molecule: LAZERTINIB
ChEMBL ID: CHEMBL4558324
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: MODOTUXIMAB
ChEMBL ID: CHEMBL3989988
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: VANDETANIB
ChEMBL ID: CHEMBL24828
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2011

Molecule: POZIOTINIB
ChEMBL ID: CHEMBL3545154
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: KBP5209
ChEMBL ID: CHEMBL4650289
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Unknown

Molecule: TARLOXOTINIB
ChEMBL ID: CHEMBL4297661
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MM-111
ChEMBL ID: CHEMBL4297556
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Unknown

Molecule: ZENOCUTUZUMAB
ChEMBL ID: CHEMBL4298025
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: TRASTUZUMAB
ChEMBL ID: CHEMBL1201585
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 1998

Molecule: PERTUZUMAB
ChEMBL ID: CHEMBL2007641
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2012

Molecule: TRASTUZUMAB EMTANSINE
ChEMBL ID: CHEMBL1743082
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2013

Molecule: LAPATINIB DITOSYLATE
ChEMBL ID: CHEMBL1201179
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2007

Molecule: AFATINIB DIMALEATE
ChEMBL ID: CHEMBL2105712
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2013

Molecule: AC-480
ChEMBL ID: CHEMBL1645462
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: ALLITINIB
ChEMBL ID: CHEMBL1947204
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CP-724714
ChEMBL ID: CHEMBL483321
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CUDC-101
ChEMBL ID: CHEMBL598797
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: JNJ-26483327
ChEMBL ID: CHEMBL3109738
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: MP-412
ChEMBL ID: CHEMBL5095024
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: TUCATINIB
ChEMBL ID: CHEMBL3989868
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2020

Molecule: S-222611
ChEMBL ID: CHEMBL3545200
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: MUBRITINIB
ChEMBL ID: CHEMBL1614707
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TAK-285
ChEMBL ID: CHEMBL1614725
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: HEMAY-022
ChEMBL ID: CHEMBL3545111
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: PYROTINIB
ChEMBL ID: CHEMBL3647420
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: AEE-788
ChEMBL ID: CHEMBL587723
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: VARLITINIB
ChEMBL ID: CHEMBL2103842
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: SAPITINIB
ChEMBL ID: CHEMBL2408045
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BMS-690514
ChEMBL ID: CHEMBL3545396
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MASOPROCOL
ChEMBL ID: CHEMBL313972
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1992

Molecule: TESEVATINIB
ChEMBL ID: CHEMBL3544983
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: CANERTINIB DIHYDROCHLORIDE
ChEMBL ID: CHEMBL545315
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: NERATINIB
ChEMBL ID: CHEMBL180022
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: DACOMITINIB
ChEMBL ID: CHEMBL2105719
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: MARGETUXIMAB
ChEMBL ID: CHEMBL2364649
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2020

Molecule: GANCOTAMAB
ChEMBL ID: CHEMBL3833344
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ERTUMAXOMAB
ChEMBL ID: CHEMBL2108029
Mechanism of Action: CROSS-LINKING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: MDX-210
ChEMBL ID: CHEMBL2109271
Mechanism of Action: CROSS-LINKING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: T-DM1
ChEMBL ID: CHEMBL2109399
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody drug conjugate

Molecule: DACOMITINIB ANHYDROUS
ChEMBL ID: CHEMBL2110732
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: NERATINIB MALEATE
ChEMBL ID: CHEMBL3989921
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: TRASTUZUMAB DERUXTECAN
ChEMBL ID: CHEMBL4297844
Mechanism of Action: BINDING AGENT
Max Phase: 4.0
Molecule Type: Antibody drug conjugate
First Approval: 2019

Molecule: TUXOBERTINIB
ChEMBL ID: CHEMBL4650279
Mechanism of Action: NEGATIVE ALLOSTERIC MODULATOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: TRASTUZUMAB DUOCARMAZINE
ChEMBL ID: CHEMBL4298178
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody drug conjugate

Molecule: KN-026
ChEMBL ID: CHEMBL4594568
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Unknown

Molecule: ZANIDATAMAB
ChEMBL ID: CHEMBL4650256
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: ANVATABART OPADOTIN
ChEMBL ID: CHEMBL4297892
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: AFATINIB DIMALEATE
ChEMBL ID: CHEMBL2105712
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2013

Molecule: AC-480
ChEMBL ID: CHEMBL1645462
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: JNJ-26483327
ChEMBL ID: CHEMBL3109738
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Small molecule

Molecule: BMS-690514
ChEMBL ID: CHEMBL3545396
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CANERTINIB DIHYDROCHLORIDE
ChEMBL ID: CHEMBL545315
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: DACOMITINIB
ChEMBL ID: CHEMBL2105719
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: DACOMITINIB ANHYDROUS
ChEMBL ID: CHEMBL2110732
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2018

Molecule: NERATINIB
ChEMBL ID: CHEMBL180022
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: NERATINIB MALEATE
ChEMBL ID: CHEMBL3989921
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2017

Molecule: SAPITINIB
ChEMBL ID: CHEMBL2408045
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PATRITUMAB
ChEMBL ID: CHEMBL2109406
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: MM-121
ChEMBL ID: CHEMBL2109402
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: AMG-888
ChEMBL ID: CHEMBL2109396
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: DULIGOTUZUMAB
ChEMBL ID: CHEMBL3137345
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: SERIBANTUMAB
ChEMBL ID: CHEMBL3545071
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: LUMRETUZUMAB
ChEMBL ID: CHEMBL3707404
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: AV-203
ChEMBL ID: CHEMBL2109401
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: ELGEMTUMAB
ChEMBL ID: CHEMBL4298013
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ISTIRATUMAB
ChEMBL ID: CHEMBL3989990
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: CDX-3379
ChEMBL ID: CHEMBL4650292
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: PATRITUMAB DERUXTECAN
ChEMBL ID: CHEMBL4594611
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Antibody drug conjugate
